N | Baseline | 18-month | Intervention vs. Control | |||
---|---|---|---|---|---|---|
Mean ± S.D. | Mean ± S.D. | Difference | P-valuea | |||
Weight, kg | Intervention | 238 | 65.4 ± 7.9 | 63.8 ± 8.2 | -1.08 | 0.003 |
Control | 1040 | 66.0 ± 8.7 | 65.4 ± 9.2 | |||
BMI, kg/m2 | Intervention | 238 | 25.7 ± 2.2 | 25.1 ± 2.3 | -0.38 | 0.007 |
Control | 1040 | 25.7 ± 2.3 | 25.5 ± 2.6 | |||
Waist, cm | Intervention | 238 | 90.8 ± 5.7 | 88.9 ± 6.5 | -1.13 | 0.039 |
Control | 1040 | 90.6 ± 5.9 | 90.0 ± 6.7 | |||
SBP, mmHg | Intervention | 238 | 133.9 ± 14.5 | 131.2 ± 14.0 | -0.91 | 0.520 |
Control | 1040 | 135.2 ± 16.1 | 132.4 ± 14.8 | |||
DBP, mmHg | Intervention | 238 | 79.6 ± 9.6 | 78.1 ± 9.0 | 0.27 | 0.778 |
Control | 1040 | 80.7 ± 10.5 | 78.4 ± 9.9 | |||
HDL-C, mg/dl | Intervention | 238 | 58.6 ± 15.0 | 58.6 ± 14.8 | 1.10 | 0.214 |
Control | 1040 | 56.6 ± 15.1 | 56.3 ± 15.3 | |||
LDL-C, mg/dl | Intervention | 238 | 134.2 ± 29.1 | 127.0 ± 27.9 | 0.59 | 0.823 |
Control | 1040 | 133.9 ± 31.5 | 127.5 ± 31.7 | |||
TG, mg/dl | Intervention | 238 | 143.6 ± 74.2 | 136.5 ± 76.2 | -25.1 | 0.021 |
Control | 1040 | 163.4 ± 131.1 | 156.7 ± 119.4 | |||
HbA1c,% | Intervention | 238 | 5.32 ± 0.39 | 5.31 ± 0.39 | -0.03 | 0.429 |
Control | 1040 | 5.35 ± 0.66 | 5.38 ± 0.57 | |||
Framingham risk score, score | Intervention | 238 | 13.9 ± 2.4 | 14.0 ± 2.5 | -0.39 | 0.022 |
Control | 1040 | 13.9 ± 2.7 | 14.1 ± 2.9 | |||
Mean 10-year CHD risk,% | Intervention | 238 | 8.7 ± 5.8 | 8.8 ± 5.9 | -0.85 | 0.027 |
Control | 1040 | 9.3 ± 6.4 | 9.8 ± 6.6 |